We are collecting authors'profile. As soon as we get, we update it. Please note this is not official profile. The information including photo is collected from web.
| Contact |
| twitter |
| Linkedin |
... I expected the medical profession of the country to welcome the reduction of the prices of cardiac stents by 85 per cent with great jubilation. My expectation, and perhaps also of all those who trust medical professionals, emanated from the simple understanding that doctors have the best interests of patients at heart. A cheap life-saving device would facilitate their ethical commitment to do good for patients. But these expectations were soon belied. Doctors felt insecure, irritated, some even attacking price control and other regulations. ...Indian Express on March 7, 2017, 1:07 a.m.
...The court had, at that time, directed that there be three-tier scrutiny of all clinical trials.Why did the drug regulator and the ministry of health wait for 10 months?Perhaps they expected the PIL on which the Supreme Court is monitoring the regulation of clinical trials to fade away.As reported in this paper, pharmaceutical companies and contract research organisations involved in clinical trials in India are indeed threatening to move trials out of the country.How far are such threats justified in light of the apex court's demand for strict monitoring of the clinical trials?In medical science, experimental drug research or clinical trials with human subjects are indispensable. ...Indian Express on Oct. 28, 2013, 12:09 a.m.